Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomization was performed by a person who was not a study interviewer or therapist using a SAS procedure and was stratified by patient performance status (self-reported ECOG scores 0 or 1 vs. 2) because this factor informs cancer treatment decision-making [33].”
From Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial (2018) · cites this paper as [33]
In the citing paper
“We are stratifying randomization by performance status because it is a key factor in MBC treatment decisions [28].”
From Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancer (2020) · cites this paper as [28]
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa064320 · Cited by 3,425
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
Marty, M., Cognetti, F., Maraninchi, D., Snyder, R., Mauriac, L., Tubiana-Hulin, M., Chan, S., Grimes, D., Antón, A., Lluch, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.173 · Cited by 1,597
Research works printed but not linked: 1
- Network NCC. 2008. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 2, ASCO-Edition 2008.
Cited by
Items 401–485 of 485
Barco, I., Chabrera, C., García‐Fernández, A., Fraile, M., Giménez, N., Vallejo, E., Zarco, P., González, S., González, C., Larrañaga, I., et al. (2022) · Breast Disease · doi:10.3233/bd-210086 · Cited by 1
“Once established, such an advanced stage of the disease has no cure, and patient mean survival is estimated at 2– 3 years [2].”
Tian, C., Yang, J., Xie, N., Tang, Y., Zhou, H., Hu, Z.-Y., & Ouyang, Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3828 · Cited by 1
Nanoliposomal System for Breast Cancer Therapy
Mustafa, G., Ahmad, M. Z., Aslam, M., Garg, A., & Ahmad, J. (2022) · Springer eBooks · doi:10.1007/978-981-19-5558-7_10 · Cited by 1
Muraleedharan, A., Kumar, S., & Mittal, R. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815079784123010007 · Cited by 1
Song, X.-M., Wang, P., Feng, R., Chetry, M., Li, E., Wu, X., Liu, Z., Liao, S., & Lin, J. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03316-0 · Cited by 1
Armstrong, S., Makris, A., Belessiotis, K., Abdul-Latif, M., Ostler, P., Shah, N., Miles, D., & Tsang, Y. M. (2024) · Clinical Oncology · doi:10.1016/j.clon.2024.03.012 · Cited by 1
Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana
Kyei, K. A., Anim-Sampong, S., Akoe, E. A., Daniels, J., Obeng-Mensah, T., Antwi, W. K., & Ainuson‐Quampah, J. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102028 · Cited by 1
“Consistent with the literature, Poll ´ an [11] and Cardoso et al., [12] stated that BC was more prevalent in women over 40 years.”
ResultNaqi, A., Khan, M. A., & Najmi, A. K. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03629-8 · Cited by 1
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro
Yu, L., Zhang, C., Liu, L.-Y., & Chen, X. (2024) · Pharmacogenomics · doi:10.1080/14622416.2024.2404819 · Cited by 1
Patient-reported outcomes in advanced breast cancer: inside the label and approval documents
Hao, Y., Krohe, M., Mazar, I., Galipeau, N., Foley, C., GLOBE, D. R., Turner‐Bowker, D. M., & Shields, A. L. (2016) · Expert Review of Quality of Life in Cancer Care · doi:10.1080/23809000.2016.1174068 · Cited by 1
Martiniuc, A., Dumitraşcu, T., Pavel, M., & Stroescu, C. (2017) · Chirurgia · doi:10.21614/chirurgia.112.2.165 · Cited by 1
Growth pattern can be used as a new characteristic to predict malignancy in breast cancer
Wang, B., Zhu, L., He, C., Tai, M., Zhou, C., Ge, G., Zhang, H., He, J., & Wang, K. (2020) · Breast Cancer · doi:10.1007/s12282-019-01041-7 · Cited by 1
Role of Ancillary Tests in Breast Fine Needle Aspiration Biopsy Cytopathology
de Beça, F. F., & Schmitt, F. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-26883-1_9 · Cited by 1
Features of tumor heterogeneity in regional metastasis of breast cancer
Konyshev, K., & Sazonov, S. V. (2021) · Kazan medical journal · doi:10.17816/kmj2021-716 · Cited by 1
Primary Tumor Surgery in De Novo Metastatic Breast Cancer: An Unresolved Controversy
(2021) · International Journal on Obstetrics and Gynecology · doi:10.51626/ijog.2022.02.00008 · Cited by 1
Kameo, S. Y. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2016.tde-05052016-201031 · Cited by 1
Exercise Safety, Feasibility and the Role of Fitbits Among Women with Stage II+ Breast Cancer
Singh, B. (2019) · Queensland University of Technology · doi:10.5204/thesis.eprints.127026 · Cited by 1
Lindeman, G. J., Fernando, T. M., Bowen, R. L., Jerzak, K. J., Song, X., Decker, T. W., Boyle, F. M., McCune, S., Armstrong, A. C., Shannon, C., et al. (2023) · doi:10.1158/1078-0432.22487573 · Cited by 1
Yang, Q., Fu, Y., Feng, W., Yu, X., Xu, N., Yang, H., & Zhang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4200023/v1 · Cited by 1
Lyseng-Williamson, K. A. (2015) · Drugs & Therapy Perspectives · doi:10.1007/s40267-015-0236-7
Downregulation of MTDH using short hairpin RNA inhibited EMT in breast cancer cells
Cao, H., Liu, Z., Ma, D., Ding, Z., Du, C., & Xie, X. (2013) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-013-1185-z
Loco-regional Breast Cancer Recurrences
Gentilini, O., & Boccardo, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-15907-2_20
Hormonoterapia przedoperacyjna u chorych na raka piersi
Dębska-Szmich, S., Krakowska, M., Czernek, U., Habib-Lisik, M., Zięba, A., & Potemski, P. (2014) · Nowotwory Journal of Oncology · doi:10.5603/njo.2014.0006
Cancer of the Breast: An Overview
Stephens, F. O., & Aigner, K. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-23368-0_12 · Cited by 1
Current Status of Clinical Genomics in Patients with Metastatic Breast Cancer
Krishnamurthy, S. (2016) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2016.07.028
Krstić, I., Ilic, M. D., Vrbić, S., & Pejčić, I. (2014) · AFMN Biomedicine · doi:10.1515/afmnai-2015-0018
Luo, Q., Adhikari, V. P., Zhao, C.-X., Wu, H., Dai, W., Li, X., Wu, Y., Wu, K., & Kong, L. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.10.017
Predicting Risk of Disease Recurrence
Yeo, B. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-41858-2_2
Eribulin in the treatment of breast cancer: an important weapon in the treatment algorithm
Zamagni, C. (2017) · Future Oncology · doi:10.2217/fon-2017-0134
Ovarian Ablation and Letrozole as Treatment for Premenopausal Women with Metastatic Breast Cancer
Mostafa, H. (2015) · Research in Oncology · doi:10.21608/resoncol.2015.470
Current guidelines of breast cancer management
Falci, C., Baretta, Z., & Monfardini, S. (2013) · doi:10.2217/ebo.12.490
Standard therapy of HER2-positive and triple negative metastatic breast cancer - present and future
Trifunović, J., & Pesic, J. (2013) · Archive of oncology · doi:10.2298/aoo1304163t
RADIATION THERAPY– AN EFFECTIVE TOOL FOR ANALGESIA IN METASTATIC BONE DISEASE IN BREAST CANCER
Negi, P., Kingsley, P. A., Sachdeva, J., & Srivastava, H. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/962
Electrochemotherapy of Breast Cancer
Campana, L. G., Matthiessen, L. W., Snoj, M., & Serša, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-48848-6_76
Role of Surgery in Lung Metastases from Breast Cancer
Shackcloth, M. J., & Love, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-56673-3_53
Neoadjuvant chemotherapy in breast cancer
Vriens (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20171213bv
Análise de um caso de câncer de mama com recidiva
da Silva, R. D. (2018) · Revista Família Ciclos de Vida e Saúde no Contexto Social · doi:10.18554/refacs.v6i1.1880
Targeting Master Regulators of the Breast Cancer Metastasis Transcriptome
Chan, T. A.-T. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada608859
Interdisziplinäre Therapie von Knochenmetastasen
Fakler, J., Todenhöfer, T., Müller, M. E., Kurth, A. A., Eberhardt, C., & Fischer, R. (2018) · Springer eBooks · doi:10.1007/978-3-662-52748-1_3
INFERRED SURVIVAL ANALYSIS OF METASTATIC BREAST CANCER IN A BRAZILIAN EXTERNAL LIBRARY
Debiasi, M., Simon, S. D., Preger, L., Cassoli, L., & Barrios, C. (2018) · Brazilian Journal of Oncology · doi:10.5935/2526-8732.20180008
Winston, S. (2019) · Principles of specialty nursing · doi:10.1007/978-3-319-76457-3_11
Zhang, R., Gao, P., Ding, J., Li, Z., & Li, J. (2019) · Breast Cancer · doi:10.1007/s12282-019-01000-2
Spectrum of Pharmacological Activity of Monoclonal Antibodies
Zaychenko, А. V., Горчакова, Н. А., Shumeiko, O. V., Klymenko, O., & Khodakivska, O. V. (2019) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs04.05.017 · Cited by 3
Abdelrahman, L. A. I. (2019) · Open Access Journal of Oncology and Medicine · doi:10.32474/oajom.2019.02.000148
Sun, Q., Wang, Y., Jin, S., Wang, C., Zhou, Y., & Guo, S. (2021) · Research Square · doi:10.21203/rs.3.rs-141171/v1
Sun, Q., Wang, Y., Jin, S., Wang, C., Zhou, Y., & Guo, S. (2021) · Research Square · doi:10.21203/rs.3.rs-315749/v1
Expression and Clinical Significance of Origin Recognition Complex Family in Breast CancerPreprint
chen, S., Jin, Z., Xin, L., Lv, L., Zhang, X., Gong, Y., & Liu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-900515/v1
Diagnostic and Prognostic implications of AAGAB expression in human breast cancerPreprint
Zhang, C. L., Chen, G., Liu, Y., Wang, C., Zeng, C., Yang, K. G., & Yin, D. (2020) · Research Square · doi:10.21203/rs.3.rs-47482/v1
Le festin d'immortalité : etude de mythologie comparée indo-européenne
Dumézil, G. (1924) · Librairie orientaliste P. Geuthner eBooks
Dutta, R., Virk, S. K., Patil, P., Bhandoria, G. P., Sarang, B., Mahajan, A., Khajanchi, M. U., Jain, S., Bains, L., Bhandarkar, P., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1052407/v1
Repetitive Painting (REPEAT) Irradiation in Stereotactic Radiotherapy Using Helical Tomotherapy
Ohkubo, Y., KUMAZAWA, T., Hirai, R., & Noda, S. (2021) · In Vivo · doi:10.21873/invivo.12706
Zheng, Y., Jin, M., Chen, S., Feng, Y., Du, J., Li, J., & Wang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1306867/v1
Rizvi, M. R. (2019) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2019.16.555935
Alarfi, H., Youssef, L. A., & Salamoon, M. (2019) · doi:10.21203/rs.2.16886/v1
INFERRED SURVIVAL ANALYSIS OF METASTATIC BREAST CANCER IN A BRAZILIAN EXTERNAL LIBRARY
Debiasi, M., Simon, S. D., Preger, L., Cassoli, L., & Barrios, C. H. (2018) · Brazilian Journal of Oncology · doi:10.5935/1806-6054.20180008
Zheng, Y., Jin, M., Chen, S., Feng, Y., Du, J., Li, J., & Wang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1306867/v2
Lindeman, G. J., Fernando, T. M., Bowen, R. L., Jerzak, K. J., Song, X., Decker, T. W., Boyle, F. M., McCune, S., Armstrong, A. C., Shannon, C., et al. (2023) · doi:10.1158/1078-0432.22487573.v1
Küemmel, S., Campone, M., Loirat, D., López‐López, R., Beck, J. T., Laurentiis, M. D., Im, S., Kim, S., Kwong, A., Steger, G. G., et al. (2023) · doi:10.1158/1078-0432.c.6530927.v1
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cellPreprint
yu, L. Y., Zhang, C., Liu, L.-Y., & Chen, X.-P. (2023) · Research Square · doi:10.21203/rs.3.rs-3447830/v1
Expression and Mechanism of Integrin Alpha 5 in Breast Cancer Bone Metastasis Model Rats
Wang, G., Xia, B., & Zheng, X. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1274
Ando, Y., Masuda, T., Hayashi, N., Kosai, K., Shibuta, S., Ono, Y., Tobo, T., Otsu, H., Hisamatsu, Y., Yoshizumi, T., et al. (2025) · Breast Cancer · doi:10.1007/s12282-025-01667-w
Macedo, T. R. D. O., Borges, M. F. D. S. O., & da Silva, I. F. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5371256
Samir, A. S., Brahim, K., Manel, B., Moez, H., Marwa, K., Rangareddy, H., & Rajhi, H. (2025) · Cureus · doi:10.7759/cureus.91113
“Several bone-targeted agents are approved and are currently considered the standard of care [9,15].”
HER Receptor, Current, and Emerging Therapeutic Targets
Tan, M. L., Yeap, J. W., & Matawali, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_258
Rosati, R., Oppat, K., Huang, Y., Kim, S., & Ratnam, M. (2020) · Figshare · doi:10.6084/m9.figshare.12421325
Rosati, R., Oppat, K., Huang, Y., Kim, S., & Ratnam, M. (2020) · Figshare · doi:10.6084/m9.figshare.12421319
Lindman, H., Wiklund, F., & Andersen, K. K. (2022) · Figshare · doi:10.6084/m9.figshare.21192292
Lindman, H., Wiklund, F., & Andersen, K. K. (2022) · Figshare · doi:10.6084/m9.figshare.21192289
Liu, Y., Wu, J., Ji, Z., Chen, L., Zou, J., Zheng, J., Lin, W., Cai, J., Chen, Y., Zheng, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24070242
A low-cost breast cancer prognosis tool using machine learning
Espinoza, I. R. G., Castro-Ponce, A., Castelló-Pons, M., Jiménez-Monferrer, S., Cardona-Ferrer, E. E., Juárez-Salazar, G., Juárez-Salazar, D. A., Chiquillo-Domínguez, M., Cruz, E. M., & González-Lozada, L. E. (2024) · Breast Disease · doi:10.1177/15581551241289699
Breast cancer treatment using radiation therapy, advantages, and disadvantages of radiation therapy
Mir, A. A., & Mir, M. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33347-7.00007-5
Brandstetter, L., Grau, A., Müller-Reiter, M., Salmen, J., Müller-Nordhorn, J., Beck, N., Heuschmann, P., Störk, S., Wöckel, A., & Reese, J. (2026) · BMC Cancer · doi:10.1186/s12885-026-15641-y
Deng, Y., Huang, W., Zeng, T., & Gao, Y. (2026) · BMC Cancer · doi:10.1186/s12885-026-15713-z
“Beyond its physical burden, many patients experience emotional and social challenges that diminish quality of life [2].”
Libraries of dynamic peptides based on reversible native chemical ligation
Reţe, C.-V. (2018) · theses.fr (ABES) · doi:10.70675/dcef1c25zb880z444bzbd13z8e3940ad970c
Contributions of radiomics in ¹⁸F-FDG PET/CT and in MRI in breast cancer
Boughdad, S. (2018) · theses.fr (ABES) · doi:10.70675/1a8762b2za62dz4c26z8154zd4a55ff7a2d7
Immuno-modulatory functions of tenascin-C in a tumor progression model
Murdamoothoo, D. (2018) · theses.fr (ABES) · doi:10.70675/0ebddce2z280az4c92z9177z76ee60326851
Brandstetter, L., Grau, A., Löffler, J., Müller-Reiter, M., Salmen, J., Reese, J., Heuschmann, P., & Wöckel, A. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10672-4
“The focus of treatment in mBC is on prolonging patient survival, providing adequate symptom management, and promoting quality of life (QoL) [1–3].”
Clark, A., Shikoh, F. Y., Letter, H. P., & Maimone, S. (2026) · Journal of Breast Imaging · doi:10.1093/jbi/wbag006
Cengiz, A. N., Cengiz, M., Bozkurt, O., Zararsız, G. E., Erakcaoğlu, A., Vicdanli, S. S., Kulak, E. Y., Dişli, A. K., Inanc, M., & Özkan, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15207788
Characterization of CTC-HER2 Status in Patients with HER2-Low Invasive Breast Cancer
Chen, J. H., Meas, S., Bassett, R. L., Sarli, V. N., Upshaw, J. R., & Lucci, A. (2026) · Cancers · doi:10.3390/cancers18203265
蔺楠, Ren, C., & Wen, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1946005
Snellen, T. I. M., Vervenne, C. M., Dezentjé, V. O., Wiersma, T., Scholten, A. N., Lips, E. H., & Peeters, M.-J. T. F. D. V. (2026) · The Breast · doi:10.1016/j.breast.2026.104945
“As ILRR is associated with a high risk of distant disease, the question remains whether all ILRR patients should undergo full body staging [61].”
Metadata
- Authors
- Cardoso, F., Harbeck, N., Fallowfield, L., Kyriakides, S., & Senkus, E.
- Affiliations
- European School of Oncology (IT)
- Ludwig-Maximilians-Universität München (DE)
- Brighton and Sussex Medical School (GB)
- Europa Donna (IT)
- Gdańsk Medical University (PL)
- Corresponding author
- Senkus, E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 23
- Pages
- vii11-vii19
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4234749243
- Cited by
- 485
- References
- 40
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 21 · 2023: 25 · 2022: 26 · 2021: 30 · 2020: 37 · 2019: 41 · 2018: 33 · 2017: 53 · 2016: 42 · 2015: 66 · 2014: 49 · 2013: 32 · 2012: 1
- FWCI
- 15.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2625 d)
- Locations
- Annals of Oncology (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- locally recurrent breast cancer, metastatic breast cancer, breast cancer diagnosis, breast cancer treatment, breast cancer follow-up, incidence, mortality, early detection, adjuvant systemic therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.